Search
Leader | 00000nz a2200037n 45 0 | ||
---|---|---|---|
001 | WKP|Q60323744 (VIAF cluster) (Authority/Source Record) | ||
003 | WKP | ||
005 | 20241121000325.0 | ||
008 | 241121nneanz||abbn n and d | ||
035 | ‡a (WKP)Q60323744 | ||
024 | ‡a 0000-0003-0521-9186 ‡2 orcid | ||
024 | ‡a 56401348000 ‡2 scopus | ||
024 | ‡a 57204105542 ‡2 scopus | ||
035 | ‡a (OCoLC)Q60323744 | ||
100 | 0 | ‡a Min Zhao ‡c researcher ORCID ID = 0000-0003-0521-9186 ‡9 en | |
670 | ‡a Author's Alterations of Ocular Hemodynamics Impair Ophthalmic Vascular and Neuroretinal Function | ||
670 | ‡a Author's Anti-angiogenic effects of a mutant endostatin: a new prospect for treating retinal and choroidal neovascularization | ||
670 | ‡a Author's Antiangiogenesis effects of endostatin in retinal neovascularization. | ||
670 | ‡a Author's CFB/C2 gene polymorphisms and risk of age-related macular degeneration: a systematic review and meta-analysis. | ||
670 | ‡a Author's Correlation of spectral domain optical coherence tomography with histology and electron microscopy in the porcine retina | ||
670 | ‡a Author's Data on SD-OCT image acquisition, ultrastructural features, and horizontal tissue shrinkage in the porcine retina | ||
670 | ‡a Author's Effects of semaphorin 3A on retinal pigment epithelial cell activity. | ||
670 | ‡a Author's Ephrin-a4 is involved in retinal neovascularization by regulating the VEGF signaling pathway. | ||
670 | ‡a Author's Expression of pro- and anti-angiogenic isoforms of VEGF in the mouse model of oxygen-induced retinopathy | ||
670 | ‡a Author's Expression of Total Vascular Endothelial Growth Factor and the Anti-angiogenic VEGF 165 b Isoform in the Vitreous of Patients with Retinopathy of Prematurity | ||
670 | ‡a Author's Interleukin-1β Level Is Increased in Vitreous of Patients with Neovascular Age-Related Macular Degeneration (nAMD) and Polypoidal Choroidal Vasculopathy (PCV). | ||
670 | ‡a Author's Intravitreal Stanniocalcin-1 Enhances New Blood Vessel Growth in a Rat Model of Laser-Induced Choroidal Neovascularization. | ||
670 | ‡a Author's KH902, a recombinant human VEGF receptor fusion protein, reduced the level of placental growth factor in alkali burn induced-corneal neovascularization. | ||
670 | ‡a Author's Macular retinoschisis associated with normal tension glaucoma | ||
670 | ‡a Author's Placental growth factor expression is reversed by antivascular endothelial growth factor therapy under hypoxic conditions | ||
670 | ‡a Author's Quercetin inhibits vascular endothelial growth factor-induced choroidal and retinal angiogenesis in vitro. | ||
670 | ‡a Author's The expression of the Slit-Robo signal in the retina of diabetic rats and the vitreous or fibrovascular retinal membranes of patients with proliferative diabetic retinopathy | ||
670 | ‡a Author's TLR4 inhibitor attenuates amyloid-β-induced angiogenic and inflammatory factors in ARPE-19 cells: Implications for age-related macular degeneration. | ||
909 | ‡a (scopus) 57204105542 ‡9 1 | ||
909 | ‡a (orcid) 0000000305219186 ‡9 1 | ||
909 | ‡a (scopus) 56401348000 ‡9 1 | ||
919 | ‡a antiangiogeniceffectsofamutantendostatinanewprospectfortreatingretinalandchoroidalneovascularization ‡A Anti-angiogenic effects of a mutant endostatin: a new prospect for treating retinal and choroidal neovascularization ‡9 1 | ||
919 | ‡a antiangiogenesiseffectsofendostatininretinalneovascularization ‡A Antiangiogenesis effects of endostatin in retinal neovascularization. ‡9 1 | ||
919 | ‡a cfbc2genepolymorphismsandriskofagerelatedmaculardegenerationasystematicreviewandmetaanalysis ‡A CFB/C2 gene polymorphisms and risk of age-related macular degeneration: a systematic review and meta-analysis. ‡9 1 | ||
919 | ‡a correlationofspectraldomainopticalcoherencetomographywithhistologyandelectronmicroscopyintheporcineretina ‡A Correlation of spectral domain optical coherence tomography with histology and electron microscopy in the porcine retina ‡9 1 | ||
919 | ‡a dataonsdoctimageacquisitionultrastructuralfeaturesandhorizontaltissueshrinkageintheporcineretina ‡A Data on SD-OCT image acquisition, ultrastructural features, and horizontal tissue shrinkage in the porcine retina ‡9 1 | ||
919 | ‡a effectsofsemaphorin3aonretinalpigmentepithelialcellactivity ‡A Effects of semaphorin 3A on retinal pigment epithelial cell activity. ‡9 1 | ||
919 | ‡a ephrina4isinvolvedinretinalneovascularizationbyregulatingthevegfsignalingpathway ‡A Ephrin-a4 is involved in retinal neovascularization by regulating the VEGF signaling pathway. ‡9 1 | ||
919 | ‡a expressionofproandantiangiogenicisoformsofvegfinthemousemodelofoxygeninducedretinopathy ‡A Expression of pro- and anti-angiogenic isoforms of VEGF in the mouse model of oxygen-induced retinopathy ‡9 1 | ||
919 | ‡a expressionoftotalvascularendothelialgrowthfactorandtheantiangiogenicvegf165bisoforminthevitreousofpatientswithretinopathyofprematurity ‡A Expression of Total Vascular Endothelial Growth Factor and the Anti-angiogenic VEGF 165 b Isoform in the Vitreous of Patients with Retinopathy of Prematurity ‡9 1 | ||
919 | ‡a interleukin1βlevelisincreasedinvitreousofpatientswithneovascularagerelatedmaculardegenerationnamdandpolypoidalchoroidalvasculopathypcv ‡A Interleukin-1β Level Is Increased in Vitreous of Patients with Neovascular Age-Related Macular Degeneration (nAMD) and Polypoidal Choroidal Vasculopathy (PCV). ‡9 1 | ||
919 | ‡a intravitrealstanniocalcin1enhancesnewbloodvesselgrowthinaratmodeloflaserinducedchoroidalneovascularization ‡A Intravitreal Stanniocalcin-1 Enhances New Blood Vessel Growth in a Rat Model of Laser-Induced Choroidal Neovascularization. ‡9 1 | ||
919 | ‡a kh902arecombinanthumanvegfreceptorfusionproteinreducedthelevelofplacentalgrowthfactorinalkaliburninducedcornealneovascularization ‡A KH902, a recombinant human VEGF receptor fusion protein, reduced the level of placental growth factor in alkali burn induced-corneal neovascularization. ‡9 1 | ||
919 | ‡a macularretinoschisisassociatedwithnormaltensionglaucoma ‡A Macular retinoschisis associated with normal tension glaucoma ‡9 1 | ||
919 | ‡a placentalgrowthfactorexpressionisreversedbyantivascularendothelialgrowthfactortherapyunderhypoxicconditions ‡A Placental growth factor expression is reversed by antivascular endothelial growth factor therapy under hypoxic conditions ‡9 1 | ||
919 | ‡a quercetininhibitsvascularendothelialgrowthfactorinducedchoroidalandretinalangiogenesisinvitro ‡A Quercetin inhibits vascular endothelial growth factor-induced choroidal and retinal angiogenesis in vitro. ‡9 1 | ||
919 | ‡a expressionoftheslitrobosignalintheretinaofdiabeticratsandthevitreousorfibrovascularretinalmembranesofpatientswithproliferativediabeticretinopathy ‡A The expression of the Slit-Robo signal in the retina of diabetic rats and the vitreous or fibrovascular retinal membranes of patients with proliferative diabetic retinopathy ‡9 1 | ||
919 | ‡a tlr4inhibitorattenuatesamyloidβinducedangiogenicandinflammatoryfactorsinarpe19cellsimplicationsforagerelatedmaculardegeneration ‡A TLR4 inhibitor attenuates amyloid-β-induced angiogenic and inflammatory factors in ARPE-19 cells: Implications for age-related macular degeneration. ‡9 1 | ||
919 | ‡a alterationsofocularhemodynamicsimpairophthalmicvascularandneuroretinalfunction ‡A Alterations of Ocular Hemodynamics Impair Ophthalmic Vascular and Neuroretinal Function ‡9 1 | ||
996 | ‡2 LC|nr 91025431 | ||
996 | ‡2 BNF|14147172 | ||
996 | ‡2 ISNI|0000000079117156 | ||
996 | ‡2 ISNI|0000000498762387 | ||
996 | ‡2 LC|n 2013035298 | ||
996 | ‡2 DNB|1155322134 | ||
996 | ‡2 NYNYRILM|379788 | ||
996 | ‡2 LC|n 2022008504 | ||
996 | ‡2 DNB|121239383X | ||
996 | ‡2 LC|n 2015024522 | ||
996 | ‡2 BNF|15519166 | ||
996 | ‡2 CYT|AC000225228 | ||
996 | ‡2 LC|no2023053239 | ||
996 | ‡2 DNB|1028558481 | ||
996 | ‡2 NSK|000424998 | ||
996 | ‡2 ISNI|0000000387107814 | ||
996 | ‡2 BNF|15678499 | ||
996 | ‡2 LC|no2008125097 | ||
996 | ‡2 ISNI|0000000084198413 | ||
996 | ‡2 LC|n 2022009810 | ||
996 | ‡2 SUDOC|22827561X | ||
996 | ‡2 DNB|1077921748 | ||
996 | ‡2 DNB|1218332395 | ||
996 | ‡2 DNB|1206714131 | ||
996 | ‡2 J9U|987007303066505171 | ||
996 | ‡2 RERO|A005850581 | ||
996 | ‡2 SELIBR|309777 | ||
996 | ‡2 DNB|1180791207 | ||
996 | ‡2 LC|n 2024041046 | ||
996 | ‡2 ISNI|0000000503858157 | ||
996 | ‡2 SUDOC|24334077X | ||
996 | ‡2 LC|n 2020013811 | ||
996 | ‡2 LC|nr 91023750 | ||
996 | ‡2 LC|no2018138611 | ||
996 | ‡2 SUDOC|201593475 | ||
996 | ‡2 SUDOC|077287282 | ||
996 | ‡2 LC|no2021062608 | ||
996 | ‡2 CYT|AC000126222 | ||
996 | ‡2 DNB|1028745508 | ||
996 | ‡2 SUDOC|196550297 | ||
996 | ‡2 SZ|1073153819 | ||
996 | ‡2 DNB|1212965442 | ||
996 | ‡2 DNB|1314127454 | ||
996 | ‡2 SELIBR|327893 | ||
996 | ‡2 LC|n 2013005874 | ||
996 | ‡2 ISNI|0000000066637283 | ||
996 | ‡2 PLWABN|9811539358105606 | ||
996 | ‡2 PLWABN|9810660151105606 | ||
996 | ‡2 NTA|155707175 | ||
996 | ‡2 DNB|1236291263 | ||
996 | ‡2 ISNI|0000000386743122 | ||
996 | ‡2 ISNI|000000005375929X | ||
996 | ‡2 ISNI|0000000107878834 | ||
996 | ‡2 RERO|A024872381 | ||
996 | ‡2 NTA|168674467 | ||
996 | ‡2 NSK|000733247 | ||
996 | ‡2 LC|n 2015043106 | ||
996 | ‡2 DNB|1021291250 | ||
996 | ‡2 VLACC|000039136 | ||
996 | ‡2 PLWABN|9810704204605606 | ||
996 | ‡2 SUDOC|251383415 | ||
996 | ‡2 LC|n 2017075089 | ||
996 | ‡2 CYT|AC000208929 | ||
996 | ‡2 SUDOC|237803569 | ||
996 | ‡2 LC|no2021064320 | ||
996 | ‡2 LC|no2005007714 | ||
996 | ‡2 NII|DA11547188 | ||
996 | ‡2 NUKAT|n 2019148901 | ||
996 | ‡2 ISNI|0000000076651345 | ||
996 | ‡2 PLWABN|9813288790805606 | ||
996 | ‡2 SUDOC|168206927 | ||
996 | ‡2 SELIBR|397138 | ||
996 | ‡2 DNB|1191787052 | ||
996 | ‡2 DNB|1073153819 | ||
996 | ‡2 BNF|17127453 | ||
996 | ‡2 BNF|16172772 | ||
996 | ‡2 LC|n 82048983 | ||
996 | ‡2 ISNI|0000000496606823 | ||
996 | ‡2 ISNI|0000000083546447 | ||
996 | ‡2 ISNI|0000000448071705 | ||
996 | ‡2 BNF|17872368 | ||
996 | ‡2 SUDOC|11026343X | ||
996 | ‡2 NDL|001148541 | ||
996 | ‡2 ISNI|0000000071817756 | ||
996 | ‡2 LC|n 81001006 | ||
996 | ‡2 ISNI|0000000409487310 | ||
996 | ‡2 NUKAT|n 2011052991 | ||
996 | ‡2 SUDOC|195683080 | ||
996 | ‡2 NTA|413994392 | ||
996 | ‡2 SUDOC|14016426X | ||
996 | ‡2 ISNI|0000000063439193 | ||
996 | ‡2 PLWABN|9811538579405606 | ||
996 | ‡2 ISNI|000000006418687X | ||
996 | ‡2 LC|no2002005955 | ||
996 | ‡2 CYT|AC000644704 | ||
996 | ‡2 KRNLK|KAC200201793 | ||
996 | ‡2 LC|n 2015049100 | ||
996 | ‡2 DNB|130648748X | ||
996 | ‡2 ISNI|0000000053329345 | ||
996 | ‡2 CYT|AC000527887 | ||
996 | ‡2 LC|n 2013031053 | ||
996 | ‡2 DNB|1249102219 | ||
996 | ‡2 LC|n 2013044601 | ||
996 | ‡2 DNB|1267848014 | ||
996 | ‡2 ISNI|0000000049339647 | ||
996 | ‡2 SUDOC|232849544 | ||
996 | ‡2 BIBSYS|90559531 | ||
996 | ‡2 DNB|13030509X | ||
996 | ‡2 ISNI|0000000410260551 | ||
996 | ‡2 ISNI|0000000513346382 | ||
996 | ‡2 SUDOC|076528987 | ||
996 | ‡2 DNB|1220877530 | ||
996 | ‡2 ISNI|0000000077880975 | ||
996 | ‡2 DNB|1210495961 | ||
996 | ‡2 RERO|A013299292 | ||
996 | ‡2 LC|n 84040260 | ||
996 | ‡2 LC|n 2008034235 | ||
996 | ‡2 DNB|1025515072 | ||
996 | ‡2 ISNI|0000000416958918 | ||
996 | ‡2 SUDOC|183593545 | ||
996 | ‡2 DNB|1340756765 | ||
997 | ‡a 0 0 lived 0 0 ‡9 1 |